Page 170 - DUOKOPT BIBLIOBOOK
P. 170

DUOKOPT  - bibliography book - CONFIDENTIAL - document for exclusive use by personnel of Laboratoires Théa – DO NOT DISTRIBUTE
                 ®









              Korean J Ophthalmol Vol.29, No.5, 2015



              A                                             ing of anti-glaucoma eyedrops containing preservatives.
                60.00
                                                            However, the cytotoxicity of preservatives has been a con-
                50.00                6.00                   siderable problem for long-term use in patients with glau-
               No. of dead cells  40.00  p < 0.001  No. of TUNEL(+) cells  4.00  p < 0.001  coma or dry eyes [17]. Therefore, preservative-free artifi-
                                                            cial tears are gaining popularity among patients with dry
                30.00
                                                            eyes, and preservative-free unit dose anti-glaucoma eye-
                20.00
                10.00         16     2.00                   drops have recently been introduced. Along these lines,
                                                   *
                  0                    0                    Cosopt-S is a unit-dose preservative-free formulation of
                                                            the dorzolamide/timolol combination.
                      Cosopt  Cosopt-S     Cosopt  Cosopt-S
                                                             Although the potential effects of dorzolamide on corneal
                        Eyedrops              Eyedrops
              B                                             endothelial cells have not been fully elucidated, topical
                                                            carbonic anhydrase inhibitors may attenuate the bicarbon-
                                                            ate efflux by blocking carbonic anhydrase in the corneal
                                                            endothelium, leading to corneal edema [8]. However, pre-
                                                            vious studies on the effect of dorzolamide on corneal de-
                                                            swelling showed that dorzolamide does not slow the recov-
              C                                             ery from induced corneal edema in normal subjects as
                                                            well as in patients with glaucoma or ocular hypertension
                                                            [18,19]. Irreversible corneal decompensation was reported
                                                            in nine patients after topical treatment with dorzolamide
                                                            [10]. Specifically, all nine cases reported in that study un-
                                                            derwent intraocular surgery and exhibited compromised
                                                            corneal endothelia. Although it is unclear how topical
              Fig. 3. (A) Comparison of the number of dead cells from live/
              dead cell assay and TUNEL(+) cells in 5 consecutive microscop-  treatment of dorzolamide affects corneal endothelium and
              ic fields between the Cosopt and Cosopt-S groups (×400). (B)   induces corneal decompensation, the authors suggested
              TUNEL stain of rabbit cornea 24 hours after Cosopt injection.   that dorzolamide can cause irreversible corneal edema in
              Several TUNEL(+) cells are present in the endothelial cell layer.
              (C) TUNEL stain of rabbit cornea 24 hours after Cosopt-S injec-  glaucoma patients with compromised corneal endothelia
              tion. TUNEL-positive cells are absent (×400).  [10]. On the other hand, the topical dorzolamide eyedrops
                                                            used in their study of corneal decompensation contained
              A                    B                        0.005% benzalkonium chloride as a preservative. Thus, we
                                                            hypothesized that the damage to the corneal endothelium
                                                            may have been due to the preservative rather than dorzol-
                                                            amide, or possibly that the preservative may have caused
                                                            additional damage to corneal endothelia in conjunction
                                                            with dorzolamide.
               Silica 3.0 kV 11.6 mm × 504 SE(U) 5/18/12  50.0 μm  No1 3.0 kV 12.8 mm × 503 SE(U) 4/26/12  50.0 μm
                                                             In this study, we compared the toxic effects on the cor-
              Fig. 4. (A) Photograph of scanning electron microscopy 24
              hours after Cosopt injection. Corneal endothelial cells have lost   neal endothelium using two different eyedrops containing
              microvilli on the cell surface and intercellular junctions are ex-  the same anti-glaucoma components, but one with preser-
              tensively destroyed (×500). (B) Photograph of scanning electron
              microscopy 24 hours after Cosopt-S injection. Corneal endotheli-  vative and the other without. In order to directly examine
              al cells continue to exhibit a hexagonal appearance with distinct   the toxic effects of the two formulations of eyedrops, we
              microvilli on the cell surface (×500). SE = secondary electron; U   injected one formulation each into the respective anterior
              = upper detector.
                                                            chambers and evaluated toxic damage to the corneal endo-
                                                            thelium after 24 hours. In the eyes injected with the pre-
              nation of 2.0% dorzolamide and 0.5% maleate timolol.   servative-containing Cosopt, corneal endothelial damage
              Fixed combination eyedrops also have the advantage of   was severe. Likewise, Cosopt-treated eyes exhibited severe
              decreased ocular toxicity due to the need for reduced dos-  corneal edema and prominent apoptosis of endothelial


              348




   170
   165   166   167   168   169   170   171   172   173   174   175